Skip to main content
. Author manuscript; available in PMC: 2009 May 18.
Published in final edited form as: Behav Neurosci. 2008 Oct;122(5):1166–1171. doi: 10.1037/a0012601

Figure 1.

Figure 1

Varenicline at doses of 0.01, 0.1, and 1.0 mg/kg does not affect contextual fear conditioning (Figure 1A). Deficits in contextual fear conditioning produced by withdrawal of chronic nicotine administration are ameliorated by varenicline (0.1 mg/kg) (Figure 1B). Significant difference (p < 0.05) from saline treated groups denoted with (*), significant difference (p < 0.05) from nicotine withdrawal groups denoted by (#).